Rigel Pharmaceuticals

+$0.02 (+1.08%) Today

$0.00 (0.00%) As of 9:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RIGL and other ETFs, options, and stocks.

About RIGL

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.

CEO

Raul R. Rodriguez

Employees

165

Headquarters

South San Francisco, California

Founded

1996

RIGL Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

1.73M

High today

$1.92

Low today

$1.81

Open price

$1.84

Volume

2.35M

52 Week high

$4.62

52 Week low

$1.80

RIGL News

Simply Wall StMay 19

Increasing losses over year doesn't faze investors as stock swells 14% this past week - Simply Wall St

Rigel Pharmaceuticals, Inc. ( ) shareholders should be happy to see the share price up 14% in the last week. But that doesn't change the reality of under-perfor

Analyst ratings

Buy

85.7%

Hold

14.3%

Sell

RIGL Earnings

-$0.16

-$0.03

$0.09

$0.22

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 2, After Hours

Why Robinhood?

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. View more

Increasing losses over year doesn't faze investors as stock swells 14% this past week - Simply Wall St

86%

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.